Cinven to Acquire Medpace for $900M

Feb 24, 2014, 08:00 by Michael Croft

Reuters | Private equity firm Cinven plans to acquire CRO Medpace for a little over $900 million. Reuters expects the deal to be announced as soon as today.

February 24, 2014 | Private equity firm Cinven plans to acquire CRO Medpace for a little over $900 million. Reuters expects the deal to be announced as soon as today. Reuters